Monitoring and Assessment Regular monitoring during IVIG therapy includes: Pain and symptom scores Quality of life measurements Repeat neurological examinations Sometimes repeat skin biopsies to assess nerve fiber density Blood tests for kidney function, blood counts, and immunoglobulin levels Potential Side Effects and Considerations While generally well-tolerated, IVIG can cause side effects including: Headache and flu-like symptoms Infusion site reactions Allergic responses Thromboembolic events (blood clots) Aseptic meningitis (rare) Renal dysfunction (particularly with pre-existing kidney issues) Patients with certain conditions, such as IgA deficiency, cardiac disease, or renal impairment, require special considerations before initiating IVIG
Additionally, some of the posttranslational modifications regulate biochemical processes by varying enzymatic activity (Knorre et al., 2009)
All unit values calculated for U-100 insulin syringes
Its a chemical that affects the central nervous system and considered a stimulant of the methylxanthine class of psychoactive drugs
It should be noted that hepatocellular neoplasms might arise in severe hepatic fibrosis
Clinical, Cosmetic and Investigational Dermatology, 10, 147153
)
)
)
